Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cancer end prostate stage |
|
Is goserelin of any benefit in end stage metastatic prostate Is goserelin of any benefit in end stage metastatic prostate cancer? 18/Jul/07. Answer:. Clinical Evidence has a chapter on metastatic prostate cancer 1. Cancer Again ? - Cancer - Prostate cancer - Kidney and bladder Cancer - Prostate cancer - Kidney and bladder - End-stage renal disease In 1985 I came down with cancer of th left kidney. It was surgically removed, Is goserelin of any benefit in end stage metastatic prostate Is goserelin of any benefit in end stage metastatic prostate cancer? Posted by roboblogger Jul 19, 2007 | Bookmark and Share IngentaConnect Mass screening for prostate cancer in patients with To determine the usefulness of prostate-specific antigen (PSA) screening for prostate cancer in patients with end-stage renal disease (ESRD), Is incidence of prostate cancer higher in patients with end stage Mass screening for prostate cancer in patients with end-stage renal disease: Comparative study. BJU Int 2006;98:794-7. Mass screening for prostate cancer in patients with end-stage in patients with end-stage renal disease. (ESRD) than in the general population 2. By contrast, it was reported that the risk. of prostate cancer in Prostate Cancer Survivability Rates At Stage T3c The most common system of determining prostate cancer stage is the confined T3c stage prostate cancer end up living for 5 years after surgery. Ablation of Stage T /T Prostate Cancer with Permanent Interstitial Purpose: To determine if stage T. 1. /T. 2. prostate cancer can be treated safely and . The rods, with a 70á°C Curie point, were implanted end to end Human Pathology : Phenotypic heterogeneity of end-stage prostate To better understand the clinical and pathologic features of end-stage, .. Natural history and treatment of early-stage prostate cancer. Prostate Cancer Treatments Determine your prostate cancer stage by using the TNM number that the doctor has At the other end of the spectrum are the newer treatments that are less Phenoxodiol slows advance of late-stage hormone refractory Phenoxodiol Delays Progression in Hormone Refractory Prostate Cancer, . sensitivity to docetaxel in these end-stage patients,Á« Professor Kelly added. Prostate Cancer Screening: More Harm Than Good? - August 1998 Prostate cancer is the second leading cause of cancer death in men in the United States.5 In addition, significant morbidity is associated with end-stage National Prostate Cancer Coalition (NPCC) Advanced Prostate Cancer: End Stage. Facing the inevitable is one of lifeÁ™s greatest challenges, whether from prostate cancer or natural causes. Google Answers: Stage IV Prostate Cancer My father is 76 years old and is in Stage IV Prostate Cancer. . better harmonizing of treatment decisions at the end of life with patient values, Advice to families about end stage or advanced prostate cancer care From a woman who endured end-stage: INFORMATION FOR PCa FAMILIES A woman who lost her father to prostate cancer advises how families can deal with the Acts of desperation end-stage prostate cancer from Bill Sardi's In a review of two trials, a slight improvement in survival of 3.3 months and 4.5 months for men with end-stage prostate cancer, was good enough for a panel Cancer ResourcesÁ”Cancer News, Cancer Conferences, Cancer Causes Mitoxantrone, prednisone combination effective for end-stage prostate cancer. "" WESTPORT, Jun 23 (Reuters Health) - The addition of mitoxantrone to Federal Consumer Information Center: Understanding Treatment Even at the end of 10 years, few men with Stage I or II and a low Gleason score will have succumbed to prostate cancer. With a median age of 72 at diagnosis |
| cancer end prostate stage |
|
after erectile prostatectomy rehabilitation enlarged prostate gland benefit cancer prostate veteran erectile dysfunction prostate cancer impotence |